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Abstract: 
 
Background: There is currently little evidence available on the perioperative practices 
concerning One Anastomosis/Mini Gastric Bypass (OAGB/MGB) and no published consensus 
amongst experts. Even the published papers are not clear on these aspects. The purpose of 
this study was to understand various perioperative practices concerning OAGB/MGB. 
 
Methods: Bariatric Surgeons from around the world were invited to participate in a 
questionnaire-based survey. Only surgeons performing this procedure were included.  
 
Results: Two hundred and ten surgeons from 39 countries with a cumulative experience of 
68,442 procedures took the survey. Surgeons described a large number of absolute (n = 55) 
and relative contraindications (n = 59) to this procedure in their practice. Approximately 
71.0 % (n = 148/208), 70.0 % (n = 147/208), and 65.0 % (n = 137/209) respectively routinely 
perform a preoperative endoscopy, screening for Helicobacter Pylori, and ultrasound scan of 
the abdomen. A minority (35.0 %, n=74/208) of the surgeons used a constant Bilio-
Pancreatic limb (BPL) length for all the patients with remaining preferring to tailor the limb 
length to the patient and approximately half (49.0 %, n = 101/206) routinely approximate 
diaphragmatic crura in patients with hiatus hernia. Some 48.5 % (n = 101/208) and 40.0 % (n 
= 53/205) surgeons respectively do not recommend routine iron and calcium 
supplementation.  
 
 
Conclusion: This survey is the first attempt to understand a range of perioperative practices 
with OAGB/MGB. The findings will help in identifying areas for future research and allow 
consensus building amongst experts with preparation of guidelines for future practice. 
 
Key Words: Mini Gastric Bypass, One Anastomosis Gastric Bypass, Single Anastomosis 
Gastric Bypass, Omega Loop Gastric Bypass, Peri-operative Practices 
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Introduction: 
 
Several authors [1-7] have now published their experience with One Anastomosis (Mini) 
Gastric Bypass (OAGB/MGB) but there is a lack of consensus regarding its indications/contra-
indications, various intraoperative details, and postoperative care. Indeed, there is scant 
evidence for these aspects as published papers have largely focussed on weight loss, 
comorbidity resolution, and complications [1-7]. 
 
The absence of published data on various perioperative practices poses difficulty for 
bariatric surgeons wishing to adopt OAGB/MGB into their routine practice. It enhances our 
dependence on the few experts and harms scientific credentials of this somewhat 
controversial [8, 9] procedure.  Absence of such data is probably the reason why despite 
several consensus meetings on this procedure, there is as yet no published consensus 
regarding various aspects of this procedure amongst experts. Without this baseline 
information, it has proved difficult to standardise this operation and identify areas of debate 
for future research.  
 
The purpose of this study was to understand various perioperative practices concerning 
OAGB/MGB in detail. It should be emphasised that this survey does not aim to identify best 
practice. We have simply aimed to understand all variations in practice concerning 
OAGB/MGB in this study to be able to collect largest possible dataset for identification of 
best practice in future studies.  
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Methods: 
 
A questionnaire-based survey (https://www.surveymonkey.co.uk/r/V33SMLD) was 
conducted of the global community of bariatric and metabolic surgeons [Table 1]. Surgeons 
were invited to take the survey on SurveyMonkey ® starting on 28th January 2017. The link to 
the survey was freely shared on the social media (Facebook Groups, Twitter, and LinkedIn 
Groups), email chat group of surgeons (Google Groups), and through personal networks. 
Facebook Groups where the information was shared were “International Bariatric Club” and 
“Bariatric and Metabolic Surgery Professionals”. On LinkedIn we used the group “Bariatric 
and Metabolic Surgery Professionals”. An email was also sent to presidents of all the 
national bariatric societies affiliated to International Federation for the Surgery of Obesity 
and Metabolic Disorders (IFSO) for circulation amongst their membership. The survey was 
closed for analysis on 18th March 2017. Basic descriptive statistics was used. Non- surgeons, 
as well as surgeons not performing OAGB/MGB, were asked to leave the survey to focus on 
surgeons with experience with this procedure. 
 
The choices offered in this survey were felt to be the most appropriate options by the 
authors. To ensure that respondents could also enter other thoughts pertinent to this 
survey, we asked for “any other thoughts” at the end.  
 
Since the purpose of this survey was to capture all variations in practice, we included all 
OAGB/MGB surgeons irrespective of their experience. We did not use any cut-off for 
experience as this survey does not aim to identify best practice and using any cut-off would 
necessarily mean that we will fail to capture some of the prevalent practices.  
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Results:  
 
A total of 541 respondents answered the survey. Out of these, 49 respondents were not 
surgeons and a further 198 surgeons declared that they did not perform OAGB/MGB. These 
respondents were asked to leave the leave the survey and their data was excluded. This left 
us with 294 surgeons who declared themselves as OAGB/MGB surgeons. Out of these 81 
surgeons did not provide any data for the survey and were hence excluded. Three sets of 
duplicate data were also excluded. We were finally left with 210 OAGB/MGB surgeons who 
completed the survey with a cumulative experience of 68,442 procedures (range 2 – 6500, 
median 114). The interquartile range was 270 (300-30).  
 
 
The nationality of Respondents and IFSO Membership: Respondents from 39 countries 
participated in the survey. Table 2 provides country-wise data for all the responses.  
 
Contraindications: Surgeons mentioned 55 absolute contraindications in their practice. 
Table 3 provides a list of absolute contraindications mentioned by at least 3 surgeons from 
different units with the number of surgeons mentioning them. Surgeons also mentioned 59 
relative contraindications in their practice. Table 4 provides a complete list of relative 
contraindications mentioned by at least 3 surgeons from different units with the number of 
surgeons mentioning them. 
 
Preoperative Assessment: Approximately 71.0 % respondents (n = 148/208) routinely 
perform a preoperative endoscopy and a similar number (70.0 %, n = 147/208) routinely 
screen patients for Helicobacter Pylori. A slightly lower percentage (65.0 %, n = 137/209) of 
respondents perform a routine ultrasound scan of the abdomen.  
 
Intraoperative Technical Details: An overwhelming 94.0 % (n=197/209) routinely use a 
bougie to size the pouch. When asked regarding the size of the bougie, surgeons reported a 
wide variation. Table 5 lists the sizes of the bougie used by at least 3 surgeons from different 
units with the number of surgeons using them. Approximately 16.0 % (n = 33/210) of the 
surgeons routinely use staple line reinforcement. Ten of these surgeons (30.3 %) use 
Seamguard® and 20/33 (60.6 %) use some sort of a reinforcement suture. The remaining 3 
/33 used reinforced Medtronic ® reinforced stapler.  
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Almost half (49.0 %, n = 101/206) of the respondents routinely approximate the 
diaphragmatic crura in patients with a hiatus hernia. A quarter of the surgeons (25.5 %, 
53/208) routinely measure the entire small bowel length and approximately 22.0 % (n = 
45/207) routinely divide the Omentum.  
 
Some 35.0 % (n=74/208) of the surgeons used a constant Bilio-Pancreatic limb (BPL) length 
for their patients with the remaining surgeons using a BPL length tailored to the patient 
characteristics. A range of fixed limb lengths was mentioned. Table 6 lists the fixed limb 
lengths mentioned by at least 3 surgeons along with the number of surgeons using them.  
 
Most surgeons (n = 179/208, 86.0 %) performed a linear stapled gastrojejunostomy followed 
by suture closure of the enterotomy. A smaller (21/208, 10.0 %) number performed a fully 
hand sewn anastomosis and the remaining 3.84 % % (n=8/208) perform a fully stapled 
gastrojejunostomy.  
 
Approximately 18.0 % (n= 38/209) surgeons routinely close the Petersen’s defect and nearly 
90.0 % of the surgeons (n = 187/208) perform a leak test for the gastro-jejunostomy. Most 
of these (154/187, 82.35 %) surgeons used methylene blue for the leak test. The remaining 
surgeons used insufflation under-water leak test. 
 
Approximately 44.0 % of surgeons (n= 92/209) used some sort of anti-reflux technique for 
gastro-jejunostomy and 55.0 % surgeons (n = 114/208) routinely use an intra-abdominal 
drain. But only 12.5 % (n = 26/208) leave a nasogastric tube postoperatively.  
 
Postoperative Inpatient Management: Twenty-eight percent (n = 58/209) perform a routine 
postoperative contrast study and most surgeons (71.0 %, n = 149/210) allow oral intake on 
either the day of surgery or first postoperative day. Twenty-nine surgeons (13.8 %) allow 
first oral intake on the 2nd postoperative day and nine (4.28 %) surgeons allow first oral 
intake on the 3rd postoperative day.  
 
Post-discharge Management: 
 
i) Marginal Ulcer Prophylaxis: Most (89.3 %, n = 185/207) surgeons routinely use marginal 
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ulcer prophylaxis with Proton Pump Inhibitors (PPI). Only 9 of these surgeons (4.8 %) 
recommend prophylaxis for a duration longer than 6 months – eight for 12 months and one 
life long. PPI prophylaxis for up to 6 months was recommended by the remaining (84.5 %). 
 
ii) Micronutrient Supplementation: When asked regarding iron supplementation, slightly 
over half (n = 107/208) routinely supplemented patients for iron. Only 43 surgeons 
(n=43/208, 20.6 %) supplemented routinely with 45 mg or more iron. Approximately sixty-
eight percent (n = 141/208) surgeons recommend routine Vitamin D supplementation 
whereas remaining surgeons (n = 67, 32.0 %) do not. When asked regarding calcium 
supplementation, approximately 40.0 % of surgeons (n = 83/205) do not recommend any 
calcium supplementation. When asked regarding dose, a wide variation in doses of Vitamin 
D and Calcium was reported by respondents, with no clear trend. Interestingly, however, 
only 31 (31/2018, 14.9 %) surgeons recommend a dose of 3000 units daily or more of 
Vitamin D and only 3 (3/205, 1.46 %) surgeons recommend Calcium Citrate 2.4 grams daily 
or more. 
 
When asked regarding Vitamin B 12 supplementation, 59.0 % surgeons (n = 121/205) 
reported routine supplementation whereas remaining (41.0 %, 84/205) did not routinely 
supplement it. Out of 90 surgeons who provided information on the route of administration 
of Vitamin B12, 33 (33/90, 36.6 %) surgeons supplement Vitamin B12 parenterally, 50 orally 
(50/90, 55.55 %), and 7 (7/90, 77.7 %) sublingually. An overwhelming 96.6 % (n = 200/207) 
recommend a multivitamin/mineral tablet after OAGB.  
 
iii) Gall Stones Prophylaxis: Approximately 28.0 % surgeons (n = 59/209) routinely use 
Ursodeoxycholic acid prophylaxis for gallstones. Most of these surgeons recommend a 
duration of up to six months for this prophylaxis with only two (2/59, 3.4 %) surgeons 
recommending it for a year. Surgeons reported a wide variation in dosages in the range of 
400 - 1200 mg daily. 
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Discussion:  
 
This survey of 210 surgeons from 39 countries with a cumulative experience of 68,442 
procedures is the first attempt to scientifically understand a number of peri-operative 
practices concerning OAGB/MGB and will open up several areas for further discussion and 
research. It could help in identifying and establishing best practice and pave the way for a 
scientific evidence-based standardisation of peri-operative care of patients undergoing 
OAGB/MGB.  
 
It was interesting to note that respondents described a large number of absolute and 
relative contraindications for this procedure. Table 3 and 4 list some of the commoner ones. 
It is worth noting that there is considerable overlap between most of the absolute and 
relative contraindications; so what is an absolute contraindication for one group of surgeons 
is only a relative contraindication for another. This is probably due to lack of data and clarity 
on the safety of this procedure in individual groups of patients. The list of contraindications 
is particularly surprising if one considers that largest published series [1] on this procedure 
does not list any contraindication at all.  Chevallier et al [6] however mentioned Barrett's 
oesophagus and severe GORD as a contraindication in their series and our group [7] too 
does not currently recommend this procedure for these groups of patients as well as those 
with large hiatus hernia. These criteria seem reasonable especially with all the concerns of 
GORD surrounding this procedure but one has to acknowledge that an adequate risk versus 
benefit analysis of OAGB in these groups of patients has not yet been made. Similar safety 
data for various subgroups of patients do not exist for other procedures either. For example, 
there is no study specifically evaluating the results with Roux-en-Y Gastric Bypass or sleeves 
in smokers, the group regarded as either an absolute or relative contraindication by a large 
number of respondents in this study.  
 
There are large variations in surgical technique too. In particular, there does not seem to be 
any consensus on whether patients with a hiatus hernia should undergo crural 
approximation and perhaps even more importantly, majority of the surgeons (65.0%) in this 
survey do not use a fixed length of the BPL and very few surgeons in this survey use a fixed 
BPL length of <200 cm. The only published paper on tailoring of limb length with OAGB 
found improved weight loss when longer limbs were used for heavier patients [10] but this 
probably comes with a risk of malnutrition requiring reoperation which was reported to be 
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approximately 0.9 % of patients reported in a different study by the same group [2]. Future 
studies need to examine risk versus benefits of different limb lengths and tailoring of limb 
lengths. It has been suggested that the ideal length of BPL with OAGB/MGB is 150 cm [11] 
just as the ideal combined length of AL and BPL with RYGB is 150 cm according to a recent 
large systematic review [12].  
 
A minority of 18.18 % (n= 38/209) surgeons routinely close the Petersen’s defect. Though 
there have been reports of Petersen’s hernia with this procedure, the incidence appears to 
be very low [13] and the current opinion of experts seems to suggest that closure of this 
defect is unnecessary with this procedure and is not without its own problems [13]. 
Whether, like RYGB, internal hernia with OAGB/MGB will become a bigger problem with 
increasing adoption of this procedure and longer follow-up on patients, remains to be seen 
but it is worth highlighting that its proponents feel fewer internal spaces and a large 
Petersen’s space should result in a significantly lower internal hernia rates with this 
procedure in comparison with the RYGB. 
 
Approximately 44.0 % of surgeons in this survey (n= 92/209) used some sort of anti-reflux 
technique for gastro-jejunostomy. Though this survey does not capture this information, it 
may be useful to understand techniques in use for prevention of GORD and examine their 
risks and benefits in future studies.  
 
The survey suggests a wide variation in vitamin and micronutrient supplementation. Recent 
American guidelines suggest that RYGB patients be supplemented with at least 3000 units of 
Vitamin D and 2.4 grams of Calcium Citrate (aimed at providing 1200-1500 mg of elemental 
calcium) daily in addition to 45-60 mg of elemental iron daily. [14]. One could reasonably 
extrapolate that OAGB/MGB patients need at least the same dosages if not more. It was of 
some concern that only 31 (31/2018, 14.9 %) surgeons in this survey recommend a dose of 
3000 units daily or more of Vitamin D and only 3 (3/205, 1.46 %) surgeons recommend 
Calcium Citrate 2.4 grams daily or more. Adequate supplementation doses of Vitamin D and 
Calcium for these patients need to be examined in future studies and a consensus reached 
on the most appropriate dosages until such studies become available. With regards to Iron, 
the exclusion of more proximal intestine seen with the OAGB could indicate a need for 
higher Iron supplementation than the RYGB. It was concerning to note that nearly half the 
surgeons did not routinely recommend the iron supplementation for their patients and only 
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a minority 20.0 % (n=43/208) used iron in recommended dosages or higher.  Similarly, 41.0 
% of surgeons (n = 84/205) do not routinely supplement Vitamin B12 though it is 
recommended patients are routinely supplemented for Vitamin B12 after RYGB [14] 
 
This study has several limitations. Although we believe we have captured most surgeons 
performing this procedure (as evidenced by the large numbers performed), it is possible that 
there are surgeons who have not taken part. However, our aim was to get a snapshot of 
prevailing preoperative practices with this procedure and we believe with 210 surgeons 
including the most experienced, we have achieved our aims. Secondly, the nature of the 
delivery mechanism of the survey (online link to national societies, personal email network, 
social media) we cannot provide a response rate but we do not believe it will skew our 
findings as we cannot see how any particular group of surgeons will be less or more likely to 
participate. Another potential weakness of the study is that it gives equal weight to 
responses from all surgeons irrespective of their experience with this procedure. That is why 
findings of this paper should be not used to influence practice until a consensus can be 
reached amongst experts. The purpose of this survey was simply to capture all variations in 
practice to enable future studies that can identify best ones amongst these. Authors would 
hence like to caution against over-interpretation of these findings. The findings of this 
survey cannot be used to benchmark the best practices concerning this procedure.  
 
The wide variation described in the results (in particular with regard to indications and 
contraindications) reflect the paucity of controlled long-term studies with the OAGB. This 
paper does not aim to identify best practice amongst a number of practices reported by the 
respondents on a range of areas. Indeed, several practices reported in this survey may be 
regarded as “non-standard” by many surgeons and open to challenge. Our aim was simply to 
capture all variations in practice to inform future studies as well as enable a consensus 
building exercise amongst experts performing this procedure.  
 
In summary, we present a snapshot of worldwide current practice in OAGB surgery.  We 
believe the results contained will open multiple areas for future research and form the basis 
for consensus building exercise amongst surgeons. 
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Conclusion: 
 
The lack of consensus and standardisation may be hindering the uptake of OAGB/MGB. This 
survey is the first scientific attempt to understand a range of perioperative practices with 
OAGB/MGB. The findings could help in identifying areas for future research and a consensus 
building amongst experts. At the same time, it should be noted that this survey makes no 
attempt to identify best practice and its findings cannot hence be used to influence the 
choices surgeons make.  
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Abbreviations: 
 
OAGB/MGB: One Anastomosis (Mini) Gastric Bypass  
IFSO: International Federation for the Surgery of Obesity and Metabolic Disorders 
RYGB: Roux-en-Y Gastric Bypass 
GORD: Gastro-Oesophageal Reflux Disease 
PPI: Proton Pump Inhibitor 
BPL: Bilio-Pancreatic Limb 
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Table 1: A Brief Questionnaire with Summary of Responses (Edited) 
 
Questions Responses 
Please confirm that you are a bariatric surgeon 
already performing OAGB/MGB 
Yes I am a bariatric 
surgeon already 
performing 
OAGB/MGB 
No, I do not 
perform 
OAGB/MGB 
No, I am not a 
bariatric 
surgeon 
Which Country Do you Work In? Respondents were provided with a complete list of 
all the countries. Data summarised in Table 2 
How many OAGB/MGB procedures have you 
personally performed till date 
 
Are there any absolute contraindications to this 
procedure in your practice? Please list them 
 
Are there any relative contraindications to this 
procedure in your practice? Please list them 
 
Do you routinely perform a preoperative upper 
gastrointestinal endoscopy? 
Yes No 
Do you routinely screen patients planned for 
OAGB/MGB for Helicobacter Pylori? 
Yes No 
Do you routinely perform a preoperative 
Ultrasound scan of the abdomen? 
Yes No 
Do you always use a bougie to size the gastric 
Pouch 
Yes No 
If the answer to the last question is "Yes", 
please provide us with the size of the bougie 
you would usually use? 
 
Do you routinely use staple line reinforcement? Yes No 
If the answer to the last question is "Yes", 
please let us know what form of Staple line 
reinforcement you use. 
 
Do you routinely approximate diaphragmatic 
crura in patients with prediagnosed or 
intraoperatively identified hiatus hernia? 
Yes No 
Do you measure the entire small bowel length Yes No 
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routinely? 
Do you divide Omentum routinely? Yes No 
Do you use a constant length of Bilio-
Pancreatic limb in all patients? Please select 
"No" if you vary limb length depending on BMI 
or other factors. 
Yes No 
If the answer to the last question is "Yes", 
please mention in the box below the fixed 
length of the BP limb in centimeters you would 
routinely use? 
 
How do you perform your Gastro-Intestinal 
Anastomosis? 
  
Do you routinely close the Petersen's defect? Yes No 
Do you routinely perform a leak test for your 
gastro-intestinal anastomosis? 
Yes No 
If the answer to the last question is "Yes", 
please mention the technique you use. 
Yes No 
Do you routinely add an anti-reflux 
modification to your gastro-intestinal 
anastomosis? 
Yes No 
Do you routinely leave an intra-abdominal 
drain? 
Yes No 
Do you routinely leave a nasogastric tube? Yes No 
Do you routinely carry out contrast study in the 
early postoperative period? 
Yes No 
Please describe when you start oral intake for 
your patients postoperatively. 
 
Do you routinely use marginal ulcer 
prophylaxis? 
Yes No 
If the answer to the last question is "Yes", 
please mention the drug used and duration of 
usage. 
 
Do you routinely supplement your patients for 
iron? 
Yes No 
 16 
If the answer to the last question is "Yes", 
please mention the dose of elemental iron 
you'd recommend daily.   
 
Do you routinely supplement your patients for 
Vitamin D? 
Yes No 
If the answer to the last question is "Yes", 
please mention the dose of Vitamin D (in 
International units) you would recommend 
daily. 
 
Do you routinely supplement your patients for 
Calcium? 
Yes No 
If the answer to the last question is "Yes", 
please mention the dose of elemental Calcium 
you'd recommend daily. 
 
Do you routinely supplement your patients for 
Vitamin B 12? 
Yes No 
If the answer to the last question is "Yes", 
please mention the route (oral or parenteral or 
sublingual etc.) and the dose of Vitamin B12 
you'd recommend daily. 
 
Do you routinely supplement your patients 
with a multivitamin/mineral tablet? 
Yes No 
Do you routinely use Ursodeoxycholic acid for 
prophylaxis of gall stones? 
Yes No 
If the answer to the last question is "Yes", 
please mention the daily dose and duration of 
such prophylaxis. 
 
Do you have any other thoughts relevant to 
this survey? 
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Table 2: Country of Origin of Respondents in Alphabetical Order 
 
Country of Origin Percentage Number of Responses 
Argentina 2.40 % 5 
Australia 4.81 % 10 
Austria 0.96 % 2 
Belgium 2.40 % 5 
Brazil 3.85 % 8 
China 0.96 % 2 
Colombia 0.48 % 1 
Costa Rica 0.48 % 1 
Croatia 0.48 % 1 
Czech Republic 0.96 % 2 
Ecuador 0.48 % 1 
Egypt 2.40 % 5 
Finland 0.48 % 1 
France 7.69 % 16 
Germany 3.37 % 7 
Greece 0.96 % 2 
India 13.46 % 28 
Iran 0.96 % 2 
Israel 2.88 % 6 
Italy 8.65 % 18 
Jordan 0.96 % 2 
Lebanon 3.37 % 7 
Malaysia 0.48 % 1 
Mexico 4.81 % 10 
Netherlands 3.85 % 8 
Norway 1.44 % 3 
Poland 0.96 % 2 
Portugal 0.96 % 2 
Russian Federation 0.48 % 1 
Saudi Arabia 2.4 % 5 
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Serbia 0.48 % 1 
Slovenia 0.48 % 1 
Spain 3.85 % 8 
Turkey 2.88 % 6 
Ukraine 0.96 % 2 
United Arab Emirates 1.44 % 3 
United Kingdom 8.65 % 18 
United States of America 0.96 % 2 
Venezuela (Bolivarian Republic 
of) 
1.44 % 3 
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Table 3: Absolute Contraindications to OAGB reported by respondents 
 
Absolute Contraindications Percentage of Respondents Number of Respondents 
Gastro-Oesophageal Reflux Disease Related 
Significant GORD symptoms 7.14 % 15 
GORD 7.61 % 16 
Large Hiatus Hernia 4.28 % 9 
Hiatus Hernia 1.90 % 4 
Oesophagitis 1.42 % 3 
Severe Oesophagitis 3.33 % 7 
Barrett’s Oesophagus 12.85 % 27 
Behaviour Related 
Smokers 6.66 % 14 
Heavy Smokers 1.42 % 3 
Alcohol Dependent 2.85 % 6 
Drug Abuse 1.90 % 4 
Unwilling to take supplements 1.90 % 4 
Vegetarian 1.90 % 4 
Age Related 
Age < 16 2.85 % 6 
Age < 18 1.42 % 3 
Young Age 1.42 % 3 
Age > 70 1.42 % 3 
Bowel Related 
Inflammatory Bowel Disease 7.61 % 16 
Crohn’s Disease 7.14 % 15 
Previous Bowel Resection 2.85 % 6 
Significant intra-abdominal adhesions  2.85 % 6 
Coeliac Disease 1.42 % 3 
Miscellaneous 
Active Severe Psychiatric Issues 4.28 % 9 
Cirrhosis of the Liver 3.80 % 8 
Chronic Liver Disease 1.42 % 3 
Family history of Gastric Cancer 1.90 % 4 
Immunosuppressed 1.42 % 3 
Steroid Dependent 1.42 % 3 
GORD: Gastro-Oesophageal Reflux Disease 
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Table 4: Relative Contraindications to OAGB reported by respondents 
 
Relative Contraindications Percentage of Respondents Number of Respondents 
Gastro-Oesophageal Reflux Disease Related 
Significant GORD symptoms 2.85 % 6 
GORD 11.42 % 24 
Large Hiatus Hernia 3.33 % 7 
Hiatus Hernia 4.28 % 9 
Oesophagitis 1.90 % 4 
Severe Oesophagitis 2.38 % 5 
Barrett’s Oesophagus 3.33 % 7 
Behaviour Related 
Smokers 6.19 % 13 
Alcohol Dependent 1.90 % 4 
Unwilling to take supplements 2.85 % 6 
Vegetarian 1.42 % 3 
Age Related 
Age < 16 1.42 % 3 
Age <30 2.85 % 6 
Young Age 2.85 % 6 
Age >60 1.90 % 4 
Young Women 4.76 % 10 
Bowel Related 
Inflammatory Bowel Disease 2.38 % 5 
Crohn’s Disease 1.42 % 3 
Significant intra-abdominal adhesions   8 
Miscellaneous 
Active Severe Psychiatric Issues 2.85 % 6 
Cirrhosis of the Liver 1.90 % 4 
Family history of Gastric Cancer 2.85 % 6 
Previous Peptic Ulcer 1.42 % 3 
Gastric Polyps 1.42 % 3 
BMI< 35 2.38 % 5 
BMI< 40 2.38 % 5 
Anaemia 2.38 % 5 
Diarrhoea 2.38 % 5 
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Helicobacter Pylori Positivity 1.90 % 4 
Previous Gastric/Bariatric Surgery 3.33 % 7 
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Table 5: Bougie Sizes used for Construction of Gastric Pouch 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bougie Sizes Used Percentage Number of Responses 
28 Fr 1.52 % 3/197 
32 Fr 6.6 % 13/197 
34 Fr 10.6 % 21/197 
36 Fr 46.2 % 91/197 
38 Fr 11.7 % 23/197 
40 Fr 8.1 % 16/197 
42 Fr 2.5 % 5/197 
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Table6: Fixed Lengths of the Bilio-Pancreatic Limb used  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixed Length of the Bilio-Pancreatic Limb Used Percentage Number of Responses 
150 cm 10.8 % 8/74 
175 +/-5 cm 13.5 % 10/74 
200 cm  62.1 % 46/74 
250 cm  4.0 % 3 
